Sage Journals: Discover world-class research

Free access

Research article

First published 2006-03

Targeted Therapy With Antineoplastons A10 and AS2-1 of High-Grade,Recurrent,and Progressive Brainstem Glioma

Stanislaw R. Burzynski, Tomasz J. Janicki, Robert A. Weaver [...]

Integrative Cancer Therapies

Free access

Other

First published 2004-03

The Present State of Antineoplaston Research (1)

Stanislaw R. Burzynski

Integrative Cancer Therapies

Free access

Other

First published 2004-03

Managing Social Conflict in Complementary and Alternative Medicine Research: The Case of Antineoplastons

Mitchell R. Hammer, Wayne B. Jonas

Integrative Cancer Therapies

Free access

Research article

First published 2005-06

Long-term Survival of High-Risk Pediatric Patients With Primitive Neuroectodermal Tumors Treated With Antineoplastons A10 and AS2-1

Stanislaw R. Burzynski, Robert A. Weaver, Tomasz Janicki [...]

Integrative Cancer Therapies

Free access

Research article

First published 2004-09

Long-Term Survival and Complete Response of a Patient with Recurrent Diffuse Intrinsic Brain Stem Glioblastoma Multiforme

Stanislaw R. Burzynski, Robert I. Lewy, Robert Weaver [...]

Integrative Cancer Therapies

Free access

Editorial

First published 2004-03

Antineoplastons and the Challenges of Research in Integrative Care

Keith I. Block

Integrative Cancer Therapies

Retricted access

Research article

First published 2018-08

Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking,Technetium 99m Radiolabeling,and In Vivo Biodistribution Studies

Mohamed H. Aboumanei, Aly A. Abdelbary, Ismail T. Ibrahim [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results

Targeted Therapy With Antineoplastons A10 and AS2-1 of High-Grade,Recurrent,and Progressive Brainstem Glioma

The Present State of Antineoplaston Research (1)

Managing Social Conflict in Complementary and Alternative Medicine Research: The Case of Antineoplastons

Long-term Survival of High-Risk Pediatric Patients With Primitive Neuroectodermal Tumors Treated With Antineoplastons A10 and AS2-1

Long-Term Survival and Complete Response of a Patient with Recurrent Diffuse Intrinsic Brain Stem Glioblastoma Multiforme

Antineoplastons and the Challenges of Research in Integrative Care

Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking,Technetium 99m Radiolabeling,and In Vivo Biodistribution Studies